Abstract
Data on fertility after autologous hematopoietic stem cell transplantation (aHSCT) in women with multiple sclerosis (MS) are inconclusive. This study aims to report on post-aHSCT menstrual resumption in a multi-center MS-women cohort. Out of 43 women, 30 (70%) recovered menses after a mean time of 6.8 months. Older age (odds ratio (OR) = 0.5, p < 0.0001) and previous pulsed cyclophosphamide (OR = 0.44, p = 0.005) were independently associated with a reduced menstrual recovery probability. Conditioning regimens’ intensity resulted not associated with post-procedure amenorrhea. Our results highlight younger age as significantly associated with menses recovery; proper fertility counseling for MS women candidated to aHSCT both prior- and post-transplantation is therefore warranted.
Original language | English |
---|---|
Pages (from-to) | 2103-2107 |
Number of pages | 5 |
Journal | Multiple Sclerosis Journal |
Volume | 27 |
Issue number | 13 |
DOIs | |
State | Published - Nov 2021 |
Externally published | Yes |
Keywords
- Aggressive multiple sclerosis
- amenorrhea
- autologous hematopoietic stem cell transplantation
- fertility
- menstrual cycle